Elscint's flourishing position in MRI is doing wonders for themedical imaging vendor's top and bottom lines. Elscint realizedrevenues of $190.9 million in fiscal 1991 (end-December)--up from$161.9 million in 1990. The increase is based on an 85% growthin
Elscint's flourishing position in MRI is doing wonders for themedical imaging vendor's top and bottom lines. Elscint realizedrevenues of $190.9 million in fiscal 1991 (end-December)--up from$161.9 million in 1990. The increase is based on an 85% growthin revenues from its MRI product line, according to the company'sannual report.
The report signals the continuation of an impressive turnaroundfor the Haifa, Israel, corporation, which teetered at the brinkof bankruptcy in the late 1980s. Net income in 1991 grew to $17.1million, an increase of 27% over 1990.
Elscint held total assets of $171.7 million at year's end,with a debt-to-equity ratio of 15.6%. Working capital more thandoubled, to total $66.6 million.
Elscint's MRI division showed strong improvement, with dollarsales of MRI systems doubling in 1991. The company realized about$25 million in sales, up from $12.4 million the previous year.Sales of CT systems jumped 29%, to $53.9 million. Service incometotaled $53.4 million, a 5.4% increase from 1990.
Elscint's recent highlights include:
Elscint's North American operations made a substantial contributionto corporate performance. Revenues from North America rose byone-third, for a total of $74.5 million. Company officials creditedthe increase to the expansion of its U.S. marketing effort.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.